Moreover, Demont et al. [18] reported that the pharmacological inhibition of TrkA with K252a and siRNA and of sortilin with siRNA resulted in the abolition of proNGF-induced invasion and migration in different breast cancer cell lines [18]. This evidence concerns the gene NTRK1 and breast cancer.